Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 23615461

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2013 May 25
First author
Cunningham D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 May 25;381(9880):1793-4. doi: 10.1016/S0140-6736(13)60849-1.
    note
    Source null
    related pmid
    23615460
    relationship
    Comment in
  2. citation
    J Comp Eff Res. 2013 Nov;2(6):537-40. doi: 10.2217/cer.13.76.
    note
    Source null
    related pmid
    24236792
    relationship
    Comment in

Authors and identifiers

  1. name
    Cunningham D
    type
    Author
  2. name
    Hawkes EA
    type
    Author
  3. name
    Jack A
    type
    Author
  4. name
    Qian W
    type
    Author
  5. name
    Smith P
    type
    Author
  6. name
    Mouncey P
    type
    Author
  7. name
    Pocock C
    type
    Author
  8. name
    Ardeshna KM
    type
    Author
  9. name
    Radford JA
    type
    Author
  10. name
    McMillan A
    type
    Author
  11. name
    Davies J
    type
    Author
  12. name
    Turner D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cunningham D
    type
    Author
  2. name
    Hawkes EA
    type
    Author
  3. name
    Jack A
    type
    Author
  4. name
    Qian W
    type
    Author
  5. name
    Smith P
    type
    Author
  6. name
    Mouncey P
    type
    Author
  7. name
    Pocock C
    type
    Author
  8. name
    Ardeshna KM
    type
    Author
  9. name
    Radford JA
    type
    Author
  10. name
    McMillan A
    type
    Author
  11. name
    Davies J
    type
    Author
  12. name
    Turner D
    type
    Author
bibliography ids
  1. nci-bib-52f8e3f70753c503a575bbd1
book metadata
content sha256
073d15a39038045d8df0ed47997e356b5f2420aa641ddfa5a94e1ce92a1390be
document type
citation
dois
  1. 10.1016/S0140-6736(13)60313-X
electronic publication date
display
2013 Apr 22
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23615461
immutable id
pubmed:23615461@073d15a39038045d8df0ed47997e356b5f2420aa641ddfa5a94e1ce92a1390be
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9880
name
Lancet (London, England)
nlm unique id
2985213R
pages
1817-26
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 May 25;381(9880):1793-4. doi: 10.1016/S0140-6736(13)60849-1.
    note
    Source null
    related pmid
    23615460
    relationship
    Comment in
  2. citation
    J Comp Eff Res. 2013 Nov;2(6):537-40. doi: 10.2217/cer.13.76.
    note
    Source null
    related pmid
    24236792
    relationship
    Comment in
outcomes validated
false
pmid
23615461
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
39663fdb48ad486edc296d0f3d42c4eb6043e205c7b61031eef8854552f92342
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 May 25
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23615461/
title
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

Preserved source evidence · Independent clinical review pending · Not medical advice